NCT02940067 (MedEx) is a NA clinical trial of MedEx in Pancreatic Cancer, sponsored by Royal Surrey County Hospital NHS Foundation Trust.

Who is sponsoring NCT02940067?

NCT02940067 is sponsored by Royal Surrey County Hospital NHS Foundation Trust.

What drugs are being tested in NCT02940067?

Interventions in NCT02940067: MedEx.

What condition does NCT02940067 study?

NCT02940067 studies Pancreatic Cancer, Pancreatitis, Chronic.

Is NCT02940067 still recruiting?

NCT02940067 is currently completed. Last updated 29 August 2018.

Last reviewed 2018-08-29 · How we verify

NCT02940067: MedEx

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhancing Fitness Before Pancreatic Surgery

Completed NA Last updated 29 August 2018

What this trial tests

NA trial testing MedEx in Pancreatic Cancer in 20 participants. Completed in 20 August 2018.

Timeline

28 March 2017

Primary endpoint
21 June 2018

20 August 2018

Quick facts

Lead sponsor	Royal Surrey County Hospital NHS Foundation Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	20
Start date	28 March 2017
Primary completion	21 June 2018
Estimated completion	20 August 2018
Sites	1 location across United Kingdom

Drugs / interventions tested

MedEx

Conditions studied

Pancreatic Cancer — all drugs for Pancreatic Cancer →
Pancreatitis, Chronic — all drugs for Pancreatitis, Chronic →

Sponsor

Royal Surrey County Hospital NHS Foundation Trust

Who can join

18 and older, any sex, with Pancreatic Cancer or Pancreatitis, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot study to investigate the effect of prehabilitation on patients undergoing elective surgery for pancreatic disease.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Berries and other natural products in the pancreatic cancer chemoprevention in human clinical trials.
Pan P, Skaer C, Yu J, Zhao H, et al · · 2017 · cited 32× · PMID 29367867 · DOI 10.3233/jbr-170159
A review of physical activity in pancreatic ductal adenocarcinoma: Epidemiology, intervention, animal models, and clinical trials.
Hsueh HY, Pita-Grisanti V, Gumpper-Fedus K, Lahooti A, et al · · 2022 · cited 17× · PMID 34750076 · DOI 10.1016/j.pan.2021.10.004
The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?
Brandi G, Turroni S, McAllister F, Frega G. · · 2021 · cited 15× · PMID 34576078 · DOI 10.3390/ijms22189914
Unlocking the Potential of Bioactive Compounds in Pancreatic Cancer Therapy: A Promising Frontier.
Brugiapaglia S, Spagnolo F, Curcio C. · · 2025 · cited 1× · PMID 40427617 · DOI 10.3390/biom15050725

Verify or expand the search:

Other recruiting trials for Pancreatic Cancer

Currently open trials in the same condition.

NCT07126158 — Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma · Phase 2 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
NCT07409272 — A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherap · Phase 3 · recruiting
NCT07236177 — B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosi · EARLY_PHASE1 · recruiting

Other Royal Surrey County Hospital NHS Foundation Trust trials

Trials by the same sponsor.

NCT07210502 — Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate · NA · not yet recruiting
NCT06638593 — MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm. · NA · recruiting
NCT07046507 — The Exploratory Handheld Optical Coherence Tomography Study in Wilson's Disease · NA · completed
NCT06613256 — Characterisation of Endothelial Cells in Different Inflammatory Pathologies · recruiting
NCT06210724 — FIT in Diverticulitis · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02940067 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Royal Surrey County Hospital NHS Foundation Trust
Last refreshed: 29 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02940067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing